Page 1141 - Clinical Small Animal Internal Medicine
P. 1141

1079


  VetBooks.ir






               119


               Disorders of Phosphorus and Magnesium
               Rosanne Jepson, BVSc, MVetMed, PhD, DACVIM (SAIM), DECVIM-CA, PGCertVetEd, FHEA, MRCVS

               Royal Veterinary College, University of London, London, UK



                 Phosphorus                                       organic form circulating as phospholipids. The remain­
                                                                  ing 30% of plasma phosphate exists in an inorganic form
               Phosphorus is vital for many physiologic roles within the   where it may be protein bound (10%), complexed to
               body, including skeletal development and structure, cell   sodium, calcium and magnesium (5%) or circulating free
                                                                                    2‐
                                                                                            ‐
               metabolism and acting as a urinary and intracellular   as anions (85%; HPO 4 , H 2 PO 4 ).
               buffer. Disorders of phosphorus homeostasis are identi­
               fied with relative frequency in clinical practice and war­  Regulation of Phosphorus
               rant consideration of their underlying etiology, careful
               monitoring  and,  in certain  circumstances, will  require   Homeostasis of calcium and phosphorus is intrinsically
               therapeutic intervention.                          linked with many of the hormones recognized in the
                 Phosphorus can be found in the body in two forms:   control of calcium also important in the regulation of
               organic and inorganic (orthophosphoric and pyrophos­  phosphorus. Traditionally, it was considered that cal­
               phoric acid). Approximately 85%, of total body phospho­  cium was tightly regulated and that phosphorus concen­
               rus is found in an organic form as hydroxyapatite   trations were maintained in a reciprocal arrangement.
               (Ca 10 (PO 4 ) 6 OH 2 ) in bone and as fluorapatite (Ca 5 (PO 4 ) 3 F)   However, it is now appreciated that independent regula­
               in teeth. Only 14% of total body phosphorus is found   tion of phosphorus is also important.
               intracellularly and 1% within the extracellular fluid (ECF)   Phosphorus homeostasis involves three major body
               compartment.                                       organ systems: intestines, bone, and kidneys (Figure 119.1).
                 Phosphorus is the principal anion in cells where it is a   Plasma phosphorus concentration is the composite effect
               component of phospholipids and phosphoproteins and   of dietary phosphorus intake, gastrointestinal absorption,
               incorporated in the structure of nucleic acids and nucle­  cellular  translocation,  and  renal  excretion.  In  a  neutral
               otides. Phospholipids (e.g., phosphatidylcholine, phos­  state of phosphorus balance, daily dietary intake of phos­
               phatidylserine) are an important part of the lipid bilayer   phorus will be countered by renal excretion such that total
               of cell membranes and are required for platelet aggrega­  body phosphorus concentrations vary little.
               tion. Phosphorus can also be found in cyclic adenosine   The main hormones traditionally cited in the regula­
               monophosphate (cAMP), which is required for intracel­  tion of phosphorus are parathyroid hormone (PTH) and
               lular signaling pathways and is incorporated in the high‐  calcitriol (1,25(OH) 2  cholecalciferol) (Figure  119.2).
               energy phosphate bonds of adenosine triphosphate   Recently, further important hormones referred to as
               (ATP) and guanosine triphosphate (GTP). Within red   phosphotonins have been identified. Phosphotonins,
               blood cells, phosphorus is found in 2,3 diphosphoglycer­  such as fibroblast growth factor 23 (FGF23), play an
               ate (2,3 DPG) which is responsible for the release of oxy­  important role regulating renal handling of phosphorus.
               gen from hemoglobin at the tissue level.           In a similar manner to PTH, FGF23 increases renal tubu­
                 Intracellular organic phosphorus can be readily con­  lar excretion of phosphorus. However, FGF23 has an
               verted  to the inorganic  form. Rapid translocation   opposing action to PTH by inhibiting production of cal­
               between the intracellular fluid and the ECF space can   citriol and therefore indirectly reducing release of phos­
               occur, resulting in substantial alteration in ECF concen­  phorus from bone and decreasing absorption of
               trations. In the ECF, 70% of plasma phosphorus is in an   phosphorus from the intestinal tract.


               Clinical Small Animal Internal Medicine Volume II, First Edition. Edited by David S. Bruyette.
               © 2020 John Wiley & Sons, Inc. Published 2020 by John Wiley & Sons, Inc.
               Companion website: www.wiley.com/go/bruyette/clinical
   1136   1137   1138   1139   1140   1141   1142   1143   1144   1145   1146